| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |